Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/24/1993 | WO1993012130A1 2'-desoxy-isoguanosines, isoster analogues and isoguanosine derivates and their use |
06/24/1993 | WO1993012129A1 Peptide nucleic acids and their effect on genetic material |
06/24/1993 | WO1993012125A1 Phosphoric acid ester of heteroring compound as medicament |
06/24/1993 | WO1993012124A1 Substituted benzimidazoles, process for their preparation as well as their use |
06/24/1993 | WO1993012122A1 Novel phosphono-succinic acid derivatives, process for producing them and medicaments containing these compounds |
06/24/1993 | WO1993012118A1 Novel substituted oxazinoisoquinoline derivatives, pharmaceutical compositions containing them and process for preparing same |
06/24/1993 | WO1993012117A1 Immunosuppressive agent |
06/24/1993 | WO1993012115A1 7'-amino-naphthazarin antibiotic derivatives |
06/24/1993 | WO1993012113A1 3-SUBSTITUTED IMIDAZO (1,5-a) AND IMIDAZO (1,5-a)-TRIAZOLO (1,5-c) QUINOXALINES AND QUINAZOLINES WITH CNS ACTIVITY |
06/24/1993 | WO1993012110A1 Benzopyran class iii antiarrhythmic agents |
06/24/1993 | WO1993012108A1 Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring |
06/24/1993 | WO1993012107A1 Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring |
06/24/1993 | WO1993012095A1 Quinazolinone antianginal agents |
06/24/1993 | WO1993012092A1 Highly water soluble bis-naphthalimides useful as anticancer agents |
06/24/1993 | WO1993012090A1 4-amino-3-acyl quinoline derivatives and their use as inhibitors of gastric acid secretion |
06/24/1993 | WO1993012089A1 New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs |
06/24/1993 | WO1993012085A1 Isatin derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
06/24/1993 | WO1993012083A1 22-oxacholecalciferol derivative and production thereof |
06/24/1993 | WO1993012081A1 20-methyl-substituted vitamin d derivates |
06/24/1993 | WO1993012070A1 New tetrahydronaphthalene derivatives |
06/24/1993 | WO1993012069A1 Novel amino alcohol derivative or salt thereof |
06/24/1993 | WO1993011868A1 Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of making and using them |
06/24/1993 | WO1993011844A1 A method for coated particles in a spray-drying plant |
06/24/1993 | WO1993011802A1 Bicycloazamacrocyclophosphonic acid, conjugates, contrast agents and preparation |
06/24/1993 | WO1993011797A1 Drug containing an atriopeptidase inhibitor and at least one calcic antagonist |
06/24/1993 | WO1993011786A1 Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
06/24/1993 | WO1993011780A1 Skin therapeutic mixture containing cold-processed aloe vera extract, with yellow sap and aloin removed |
06/24/1993 | WO1993011777A1 Amphotericin b composition with enhanced antifungal activity |
06/24/1993 | WO1993011775A1 Transdermal azidothymidine |
06/24/1993 | WO1993011774A1 Treatment of periodontal disease with alendronate |
06/24/1993 | WO1993011773A1 New combination of formoterol and budesonide |
06/24/1993 | WO1993011772A1 Glycosylated steroid derivatives for transport across biological membranes and process for making same |
06/24/1993 | WO1993011771A1 Use of peripheral-type benzodiazepine sites for treatment of cns trauma or disease |
06/24/1993 | WO1993011770A1 Treatment of colorectal cancer |
06/24/1993 | WO1993011769A1 Carcinostatic |
06/24/1993 | WO1993011768A1 Pyridyl compounds for psoriasis treatment |
06/24/1993 | WO1993011767A1 Transdermal delivery of (e)-1,2,5,6-tetrahydro-1-methyl-3-pyridine-carboxaldehyde-o-methyloxine hcl and related compounds in the treatment of cognitive disorders and for analgesia |
06/24/1993 | WO1993011766A1 1,4-dihydropyridines for use in the treatment of dermatosis |
06/24/1993 | WO1993011765A1 Novel use of (+)-2-nitroxyethyl apovincaminate |
06/24/1993 | WO1993011763A1 Use of cytochalasins for inhibiting viral replication |
06/24/1993 | WO1993011762A1 Use of app modulators for the manufacture of a medicament for the treatment of amyloidosis |
06/24/1993 | WO1993011761A1 Aryl-triflates and related compounds |
06/24/1993 | WO1993011760A1 Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase |
06/24/1993 | WO1993011759A1 Antithrombotic diaminoalkanoic acid derivatives |
06/24/1993 | WO1993011758A1 N-aminoalkyl amide inhibitors of protein kinase c |
06/24/1993 | WO1993011756A1 Medicament for treatment of protozoal infections |
06/24/1993 | WO1993011755A1 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
06/24/1993 | WO1993011752A1 Defoaming composition |
06/24/1993 | WO1993011750A1 Ulcer prevention and treatment composition and method |
06/24/1993 | WO1993011747A1 Suspension aerosol formulations |
06/24/1993 | WO1993011745A1 Medicaments |
06/24/1993 | WO1993011744A1 Medicaments |
06/24/1993 | WO1993011743A1 Medicaments |
06/24/1993 | WO1993011739A1 Oral compositions for suppressing mouth odors |
06/24/1993 | WO1993011735A1 Treatment of fungal infections |
06/24/1993 | WO1993011668A1 Methods and compositions for reducing multi-drug resistance |
06/24/1993 | WO1993011657A2 The use of psoralen compounds to inhibit restenosis following angioplasty |
06/24/1993 | WO1993010091A3 Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation |
06/24/1993 | WO1993009791A3 Use of amphotericin b derivatives as protease inhibitors |
06/24/1993 | WO1993009762A3 Method for extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents |
06/24/1993 | WO1993006811A3 Vanadium compositions |
06/24/1993 | WO1992015304A3 Kappa receptor agonists in the treatment of cerebral ischaemia |
06/24/1993 | DE4241128A1 Transdermal aspirin dosage forms - for antithrombotic therapy or cancer prophylaxis |
06/24/1993 | DE4142319A1 Wundantiseptikum Wound antiseptic |
06/24/1993 | DE4141928A1 Neue phosphonobernsteinsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel New phosphonobernsteinsaeurederivate, process for their production and pharmaceutical compositions containing them |
06/24/1993 | DE4141646A1 Synergistic compsn. comprising nilvadipine and captopril - for treatment of hypertension, angina pectoris and coronary insufficiency |
06/24/1993 | CA2654849A1 Fluorocarbon aerosol medicaments |
06/24/1993 | CA2356145A1 New combination of formoterol and budesonide |
06/24/1993 | CA2126242A1 Aryl-triflates and related compounds |
06/24/1993 | CA2126216A1 7'-amino-naphthazarin antibiotic derivatives |
06/24/1993 | CA2126198A1 New tetrahydronaphthalene derivatives |
06/24/1993 | CA2126101A1 Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr) |
06/24/1993 | CA2125980A1 A method for coating particles in a spray-drying plant |
06/24/1993 | CA2125966A1 Peptide nucleic acids and their effect on genetic material |
06/24/1993 | CA2125867A1 Phosphonosuccinic acid derivatives, processes for their preparation and medicaments containing these compounds |
06/24/1993 | CA2125681A1 4-amino-3-acyl quinoline derivatives and their use as inhibitors of gastric acid secretion |
06/24/1993 | CA2125575A1 Oral compositions for suppressing mouth odors |
06/24/1993 | CA2125404A1 Use of peripheral-type benzodiazepine sites for treatment of cns trauma or disease |
06/24/1993 | CA2125386A1 Novel use of 2-nitroxyethyl (+)apovincaminate |
06/24/1993 | CA2125293A1 Treatment of colorectal cancer |
06/24/1993 | CA2125279A1 Methods and compositions for reducing multi-drug resistance |
06/24/1993 | CA2125190A1 Skin therapeutic mixture containing cold-processed aloe vera extract, with yellow sap and aloin removed |
06/24/1993 | CA2125142A1 Highly water soluble bis-naphthalimides useful as anticancer agents |
06/24/1993 | CA2124826A1 Isatin derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
06/24/1993 | CA2124689A1 Substituted benzimidazoles, process for their preparation as well as their use |
06/24/1993 | CA2123780A1 Amphotericin b composition with enhanced antifungal activity |
06/24/1993 | CA2122585A1 Transdermal azidothymidine |
06/24/1993 | CA2122498A1 Treatment of periodontal disease with alendronate |
06/24/1993 | CA2121833A1 Benzopyran class iii antiarrhythmic agents |
06/24/1993 | CA2117332A1 Glycosylated steroid acid derivatives for transport across biological membranes and process for making same |
06/24/1993 | CA2104372A1 Stable salts of (+)-(1s,2r)-2-¬¬n-(2-hydroxylamino-2-oxoethyl) -n-methyl-amino|carbonyl|cyclohexane-1-carboxylic acid, pro ess for their preparation and pharmaceutical compositions containing them |
06/24/1993 | CA2085913A1 Heterocyclic derivatives |
06/23/1993 | WO1993011757A1 Drug formulations for parenteral use |
06/23/1993 | EP0548024A2 Aminosulphonic acid derivatives and process for their preparation |
06/23/1993 | EP0548018A1 Imidazoles |
06/23/1993 | EP0548017A1 Thiazoles |
06/23/1993 | EP0547952A1 Use of modafinil for the manufacture of an antiischemic medicament |
06/23/1993 | EP0547827A1 Indole and benzimidazole-substituted dihydropyrimidine derivatives useful as A-II receptors antagonists |
06/23/1993 | EP0547727A2 Skin and hands composition containing disinfectants and antiseptics |
06/23/1993 | EP0547708A1 Saccharin derivative proteolytic enzyme inhibitors |